Kiko “Kla” ta nifiká?
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
Dilated Cardiomyopathy (DCM) in Manchester Terriers is a serious genetic heart condition that can be detected early through a specialized DNA test. This test helps identify carriers and affected dogs, enabling responsible breeding decisions to reduce the risk of DCM in future generations. Early detection via DNA testing is crucial for managing the health and longevity of Manchester Terriers. By using the DCM DNA test, breeders and owners can ensure healthier bloodlines and improve overall breed welfare. Regular screening supports proactive care and timely veterinary intervention. Protect your Manchester Terrier’s heart health with reliable genetic testing today. Stay informed and keep your dog safe from DCM risks.
The DNA test for Dilated Cardiomyopathy (DCM) in Manchester Terriers helps identify genetic mutations linked to this serious heart condition. Early detection through testing allows breeders and owners to make informed decisions to reduce the risk of passing DCM to future generations. This test is crucial for maintaining the health and longevity of Manchester Terriers. Regular screening supports proactive veterinary care and management. Overall, DNA testing is a valuable tool in promoting responsible breeding and canine well-being.
E tèst di DNA aki ta inkluí kuminsando for di nos pakete Basic — i tambe ta parti di e paketenan Basic, Standard, Advanced, Complete.
Wak e paketenan di tèst di DNA →Dilated Cardiomyopathy (DCM) is a serious heart condition that affects the heart muscle, leading to a decreased ability of the heart to pump blood effectively. In Manchester Terriers, DCM can result in significant health issues, including heart failure and arrhythmias. This condition is characterized by the dilation of the heart chambers, particularly the left ventricle, which impairs the heart's function.
Research has identified specific genetic mutations associated with DCM in certain dog breeds, including Manchester Terriers. These mutations can disrupt the normal function of cardiac muscle cells, leading to the progressive deterioration of heart structure and function. Understanding the genetic basis of DCM is crucial for breeders and owners, as it allows for informed decisions regarding breeding practices and the management of affected dogs.
Dogs with DCM may exhibit a range of symptoms, including lethargy, coughing, difficulty breathing, and a decreased tolerance for exercise. In some cases, the condition may progress without noticeable symptoms until it reaches an advanced stage. Diagnosis typically involves a combination of physical examinations, imaging techniques such as echocardiograms, and electrocardiograms (ECGs) to assess the heart's structure and rhythm.
DNA testing for DCM in Manchester Terriers is a valuable tool for identifying carriers of the genetic mutations associated with the disease. Knowing a dog's genetic status can help breeders make informed choices to reduce the prevalence of DCM in the breed. Additionally, owners can be proactive in monitoring the health of their dogs and implementing preventive measures if necessary.
While there is no cure for DCM, various management strategies can help improve the quality of life for affected dogs. Treatment may include medications to manage heart function, dietary changes, and regular veterinary check-ups to monitor the condition. In some cases, lifestyle modifications, such as reducing stress and ensuring a suitable exercise regimen, are also recommended.
Understanding and addressing Dilated Cardiomyopathy in Manchester Terriers through genetic testing and proactive management is essential for promoting the health and longevity of the breed. By raising awareness of this condition, breeders and owners can work together to reduce the impact of DCM and ensure a better quality of life for affected dogs.
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
No. E animal ta generalmente salú pero por transmití e mutashon na su yu.
E ta karga dos kopia mutá. Ta spera señalnan klíniko dependiendo di e malesa. E no mester wòrdu kriá.
Algun malesa ta mará na sekso, pues nan ekspreshon ta varia dependiendo di e sekso di bestia.
This DNA test detects the mutation associated with Dilated Cardiomyopathy In Manchester Terrier (DCM-MT) in order to identify clear, carrier, or at-risk animals.
Prueba di DNA ta yuda kriadónan plania parehamentu mas sigur i redusí e riesgo di transmití e mutashon na yunan.
E moda di herensia raportá pa e tèst aki ta Outosomal Resesivo.
This test analyses the mutation ABCC9 c.3557G>A.
No nesesariamente. Interpretashon ta dependé di e patronchi di herensia i e genotipo resultante.
Furrow Eva, Tate Nicole, Minor Katie, Martinson Shannon, Larrabee Shannon, Anttila Marjukka, Sleeper Meg, Henthorn Paula. An ABCC9 Missense Variant Is Associated with Sudden Cardiac Death and Dilated Cardiomyopathy in Juvenile Dogs. Genes (Basel). 2023 Apr 27;14(5):988. doi: 10.3390/genes14050988.
Bo privasidat, bo eskoho
Nos ta usa kuki esensial pa manehá e wèpsait. Kuki opshonal (manera dunadónan di kontenido inkorporá) ta desabilitá pa default i ta wòrdu aktivá solamente si bo ta di akuerdo. Bo por kambia bo eskoho na kualke momento usando e boton “Cookies”.
Ta nesesario pa karakterístikanan prinsipal i seguridat. Semper aktivá.
Ta mehorá funshonnan manera sparmentu di preferensia òf inkorporashon no-propaganda.
Yuda nos komprondé e uso di e wèpsait. Deshabilitá pa default.
Propaganda/tracking atraves di wèpsaitnan (algun video/mapa ta inkorporá). Deshabilitá pa default.